Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kodiak SciencesKOD -0.94%27 EV-to-OCF is -15.79 as of Aug. 17, 2026. GuruFocus rates KOD with a GF Score™ of 27/100. The stock has 4 warning signs investors should review. Among 1,410 Biotechnology companies, Kodiak Sciences ranks better than 77.16% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Kodiak Sciences's Enterprise Value is $2,502.42 Mil.
Kodiak Sciences's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-158.51 Mil. Therefore, Kodiak Sciences's EV-to-OCF for today is -15.79.
The historical rank and industry rank for Kodiak Sciences's EV-to-OCF or its related term are showing as below:
KOD'
s EV-to-OCF Range Over the Past 10 Years
Min: -16.59 Med: 0 Max: -15.35
Current: -15.79
During the past 10 years, the highest EV-to-OCF of Kodiak Sciences was -15.35. The lowest was -16.59. And the median was .
KOD's EV-to-OCF is ranked better than 77.16% of 1410
companies
in the Biotechnology industry
Industry Median: -3.625
vs KOD: -15.79
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Kodiak Sciences's PE Ratio (TTM) for today is calculated as:
Kodiak Sciences's share price for today is $40.98.
Kodiak Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.190.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Kodiak Sciences EV-to-OCF Related Terms
Kodiak Sciences EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Kodiak Sciences's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Kodiak Sciences's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kodiak Sciences EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kodiak Sciences's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Kodiak Sciences's EV-to-OCF falls into.
Kodiak Sciences's current Enterprise Value is $2,502.42 Mil.
Kodiak Sciences's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-158.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kodiak Sciences (KOD) has a EV-to-OCF of -15.79 as of Aug. 17, 2026. According to the industry distribution chart, Kodiak Sciences ranks #322 out of 1410 companies in the Biotechnology industry, placing it in the top 22.8%.
Is Kodiak Sciences' EV-to-OCF too high?
Kodiak Sciences' current EV-to-OCF is -15.79. Based on the distribution chart, Kodiak Sciences ranks #322 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kodiak Sciences has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Kodiak Sciences' EV-to-OCF compare to BEAM and TARS?
According to the Biotechnology industry distribution chart, Kodiak Sciences ranks #322 out of 1410 companies for EV-to-OCF. This places Kodiak Sciences in the top 23% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Kodiak Sciences's current EV-to-OCF is -15.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kodiak Sciences stock overvalued right now?
Kodiak Sciences (KOD) has a current EV-to-OCF of -15.79. The current EV-to-OCF is -15.79. Kodiak Sciences' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Kodiak Sciences (KOD), the current EV-to-OCF is -15.79 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.
27GF Score
Get the complete analysis for KOD
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KOD has been successfully added to your 
